Answers are grounded in this paper and cite their sources.
These results confirm that warfarin is associated with a high bleeding rate in patients with venous thromboembolism and cancer. Prolonged treatment with low-molecular-weight heparin may be as effective as oral anticoagulants and may be safer in these cancer patients.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: